Search for: "IN RE CENTOCOR" Results 1 - 20 of 43
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Dec 2006, 5:13 pm
" In re Centocor, Serial No. 78448489 (November 29, 2006) [not citable].Examining Attorney Evelyn Bradley relied on a dictionary definition of "programmed" and on Internet excerpts and NEXIS articles using the phrase "programmed protein" or the individual words in various medical contexts. [read post]
12 Feb 2010, 9:29 am by Michael C. Smith
SandenVendo)or judgment as a matter of law prior to submission to the jury (Southwest EFuels v. 3T), the jury not finding it, or granting a JMOL after the jury finds it (Centocor v. [read post]
9 Sep 2009, 7:14 am
– Dispute between Wyeth and Dexel (The IP Factor) EpiPen (Epinephrine) – US: King Pharmaceuticals, Meridian Medical Technology file patent infringement suit against Teva following Para IV certification (Patent Docs) Seroxat (Paroxetine) – Israel: not even sublime, just ridiculous – Israel PTO decision in Unipharm v SmithKline Beecham (America-Israel Patent Law) Stelara (Ustekinumab, anti-IL-12 antibody) – Centocor seeks review of BPAI… [read post]
7 Dec 2011, 11:32 am by Bexis
Centocor, Inc., 2008 WL 2565065, at *4 (D.N.J. [read post]
20 May 2009, 5:18 am
: Dr Reddy’s post grant opposition against Pfizer’s Champix patent (Spicy IP) Tanzania generic pharma sector set for growth (Afro-IP) US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Patent Baristas) (Ars Technica) (Patently-O) (IP Watchdog) (The Prior Art) (Patent Docs) (Patents4Life) US: Obvious-type double patenting and splitting… [read post]
4 Jul 2009, 11:06 pm
Très critique, ce rapport met en exergue un "coût prohibitif" du brevet européen, une forte insécurité juridique, une qualité des brevets "inconsistante", une "bulle-brevets", avant de préconiser la création d'une cour européenne… [read post]
29 Dec 2010, 12:54 pm by Bexis
  That is, it’s better than expected if you’re a retailer or a recipient. [read post]
21 Jan 2016, 12:50 pm
”  Id.We’re pleased that the latest threat to the LID has gone by the boards. [read post]
30 May 2019, 2:02 pm by Lawrence B. Ebert
Allergan, 796F.3d at 1309; see also In re ’318 Patent Infringement Litig.,583 F.3d 1317, 1324 (Fed. [read post]